This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Cobicistat
From Proteopedia
(Difference between revisions)
(New page: <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene=''> Cobicistat, sold under the brand name Tybost, is a medication for use in the treatment of h...) |
|||
| Line 1: | Line 1: | ||
| - | <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene=''> | + | <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='98/989322/Cv/1'> |
Cobicistat, sold under the brand name Tybost, is a medication for use in the treatment of human immunodeficiency virus infection (HIV/AIDS). Its major mechanism of action is through the inhibition of human CYP3A proteins. | Cobicistat, sold under the brand name Tybost, is a medication for use in the treatment of human immunodeficiency virus infection (HIV/AIDS). Its major mechanism of action is through the inhibition of human CYP3A proteins. | ||
Revision as of 14:44, 29 August 2023
| |||||||||||
